REGγ proteasome mediates degradation of the ubiquitin ligase Smurf1

FEBS Letters

Volumn 584, Issue 14, 2010, Pages 3021-3027

  Nie, Jing ^a,b   Wu, Min ^c   Wang, Jian ^a,b   Xing, Guichun ^a,b   He, Fuchu ^a,b   Zhang, Lingqiang ^a,b,c  

^a TSINGHUA UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Proteasome; Protein degradation; REG ; Smad ubiquitination regulatory factor 1; Ubiquitin

Indexed keywords

GLUTATHIONE; PROTEASOME; PROTEIN REGGAMMA; PROTEIN SMURF1; PROTEIN SMURF2; SMAD UBIQUITINATION REGULATORY FACTOR 1; SMAD UBIQUITINATION REGULATORY FACTOR 2; SMAD UBIQUITINATION REGULATORY FACTOR 5; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG; AUTOANTIGEN; KI ANTIGEN; LIGASE; UBIQUITIN;

ARTICLE; CELL STRAIN HEK293; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; NEURAL STEM CELL; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN INTERACTION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; ANIMAL; GENETICS; METABOLISM; MOUSE; TRANSGENIC MOUSE; UBIQUITINATION;

ANIMALS; AUTOANTIGENS; LIGASES; MICE; MICE, TRANSGENIC; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UBIQUITINATION;

EID: 77954176625     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.05.034     Document Type: Article

References (34)

1. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 1996, 65:801-847.
2. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 2003, 426:895-899.
3. Orlowski M., Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch. Biochem. Biophys. 2003, 415:1-5.
4. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
5. Ma C.P., Slaughter C.A., DeMartino G.N. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J. Biol. Chem. 1992, 267:10515-10523.
6. Dubiel W., Pratt G., Ferrell K., Rechsteiner M. Purification of an 11 S regulator of the multicatalytic protease. J. Biol. Chem. 1992, 267:22369-22377.
7. Kloetzel P.M., Ossendorp F. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 2004, 16:76-81.
8. Realini C., Jensen C.C., Zhang Z., Johnston S.C., Knowlton J.R., Hill C.P., Rechsteiner M. Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J. Biol. Chem. 1997, 272:25483-25492.
9. Rechsteiner M., Hill C.P. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol. 2005, 15:27-33.
10. Li X., Lonard D.M., Jung S.Y., Malovannaya A., Feng Q., Qin J., Tsai S.Y., Tsai M.J., O'Malley B.W. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell 2006, 124:381-392.
11. Chen X., Barton L.F., Chi Y., Clurman B.E., Roberts J.M. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGγ proteasome. Mol. Cell 2007, 26:843-852.
12. Li X., Amazit L., Long W., Lonard D.M., Monaco J.J., O'Malley B.W. Ubiquitin- and ATP- independent proteolytic turnover of p21 by the REGγ-proteasome pathway. Mol. Cell 2007, 26:831-842.
13. Murata S., Kawahara H., Tohma S., Yamamoto K., Kasahara M., Nabeshima Y., Tanaka K., Chiba T. Growth retardation in mice lacking the proteasome activator PA28gamma. J. Biol. Chem. 1999, 274:38211-38215.
14. Barton L.F., Runnels H.A., Schell T.D., Cho Y., Gibbons R., Tevethia S.S., Deepe G.S., Monaco J.J. Immune defects in 28-kDa proteasome activator gammadeficient mice. J. Immunol. 2004, 172:3948-3954.
15. Zhang Z., Zhang R. Proteasome activator PA28 regulates p53 by enhancing its MDM2-mediated degradation. EMBO J. 2008, 27:852-864.
16. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968.
17. Henke R.T., Haddad B.R., Kim S.E., Rone J.D., Mani A., Jessup J.M., Wellstein A., Maitra A., Riegel A.T. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin. Cancer Res. 2004, 10:6134-6142.
18. Sakakura C., Hagiwara A., Yasuoka R., Fujita Y., Nakanishi M., Masuda K., Kimura A., Nakamura Y., Inazawa J., Abe T., Yamagishi H. Amplification and overexpression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int. J. Cancer 2000, 89:217-223.
19. Zhou H., Yan J., Luo W., Ayala G., Lin S., Erdem H., Ittmann M., Tsai S.Y., Tsai M.J. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005, 65:7976-7983.
20. Moriishi K., Okabayashi T., Nakai K., Moriya K., Koike K., Murata S., Chiba T., Tanaka K., Suzuki R., Suzuki T., Miyamura T., Matsuura Y. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J. Virol. 2003, 77:10237-10249.
21. Ying H., Furuya F., Zhao L., Araki O., West B.L., Hanover J.A., Willingham M.C., Cheng S.Y. Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression. J. Clin. Invest. 2006, 116:2972-2984.
22. Zhu H., Kavsak P., Abdollah S., Wrana J.L., Thomsen G.H. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 1999, 400:687-693.
23. Yamashita M., Ying S.X., Zhang G.M., Li C., Cheng S.Y., Deng C.X., Zhang Y.E. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 2005, 121:101-113.
24. Wang H.R., Zhang Y., Ozdamar B., Ogunjimi A.A., Alexandrova E., Thomsen G.H., Wrana J.L. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003, 302:1775-1779.
25. Narimatsu M., Bose R., Pye M., Zhang L., Miller B., Ching P., Sakuma R., Luga V., Roncari L., Attisano L., Wrana J.L. Regulation of planar cell polarity by Smurf ubiquitin ligases. Cell 2009, 137:295-307.
26. Tian C., Xing G., Xie P., Lu K., Nie J., Wang J., Li L., Gao M., Zhang L., He F. KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat. Cell Biol. 2009, 11:580-591.
27. Li S., Lu K., Wang J., An L., Yang G., Chen H., Cui Y., Yin X., Xie P., Xing G., He F., Zhang L. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. Mol. Cell. Biochem. 2010, 338:11-17.
28. Lu K., Yin X., Weng T., Xi S., Li L., Xing G., Cheng X., Yang X., Zhang L., He F. Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1. Nat. Cell Biol. 2008, 10:994-1002.
29. Scheffner M., Nuber U., Huibregtse J.M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995, 373:81-83.
30. Rotin D., Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2009, 10:398-409.
31. Ingham R.J., Gish G., Pawson T. The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture. Oncogene 2004, 23:1972-1984.
32. Zhao M., Qiao M., Harris S.E., Oyajobi B.O., Mundy G.R., Chen D. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J. Biol. Chem. 2004, 279:12854-12859.
33. Bloom J., Amador V., Bartolini F., DeMartino G., Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 2003, 115:71-82.
34. Coulombe P., Rodier G., Bonneil E., Thibault P., Meloche S. N-terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol. Cell. Biol. 2004, 24:6140-6150.